Literature DB >> 6803310

Anti-aggregatory actions of calcium channel blockers in cat platelets.

G A Schmunk, A M Lefer.   

Abstract

Four calcium channel blockers, verapamil, nifedipine, nisoldipine and nimodipine were studied in terms of their ability to inhibit platelet aggregation in cat platelet rich plasma by optical aggregometry. Only verapamil and nisoldipine significantly inhibited aggregation in cat platelets to ADP (2 microM). None of the calcium channel blockers exerted marked inhibition of aggregation induced by 1mM arachidonic acid. However, verapamil produced a moderate but significant inhibition of aggregation to arachidonic acid. Increasing the calcium ion concentration could reverse this inhibition. Thus, there are significant differences in the anti-aggregatory activity of calcium channel blockers in cat platelet rich plasma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803310

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  6 in total

1.  [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].

Authors:  K Schrör; G Latta; H Darius; W Klaus; R Ziegler
Journal:  Klin Wochenschr       Date:  1985-01-02

2.  The pharmacological effects of allicin, a constituent of garlic oil.

Authors:  P R Mayeux; K C Agrawal; J S Tou; B T King; H L Lippton; A L Hyman; P J Kadowitz; D B McNamara
Journal:  Agents Actions       Date:  1988-08

Review 3.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

4.  Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.

Authors:  J Timar; H Chopra; X Rong; J S Hatfield; S E Fligiel; J M Onoda; J D Taylor; K V Honn
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine.

Authors:  K V Honn; J M Onoda; C A Diglio; M M Carufel; J D Taylor; B F Sloane
Journal:  Clin Exp Metastasis       Date:  1984 Jan-Mar       Impact factor: 5.150

Review 6.  The pharmacology of nisoldipine.

Authors:  A Knorr
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.